非血缘关系造血干细胞移植(unrelated donor HSCT)在国内外日益普及,单倍型相合造血干细胞移植(haploidentical HSCT)和减低预处理剂量的造血干细胞移植(HCST with reduced.intensity conditioning regimens)的数量逐年增多,这些HSCT与更高组织...
基于28个网页-相关网页
若进行HLA半相合造血干细胞移植(hematopoieticstemcelltransplantation,HSCT),则有90%的患者能找到供者,本文旨在探索HLA半相合HSCT治疗恶性血液病的可行性。
基于4个网页-相关网页
若进行HLA半相合造血干细胞移植(hematopoietic stem cell transplantation,HSCT),则有90%的患者能找到供者,本文旨在探索HLA半相合HSCT治疗恶性血液病的可行性.
基于2个网页-相关网页
背景:人类白细胞抗原(HLA)半相合造血干细胞移植由于供源广泛,在儿科具有广阔的应用前景。
Background: HLA haploidentical bone marrow is a potential source of doner for children for its availability.
背景:移植后造血干细胞的顺利归巢是单倍相合骨髓移植成功的关键。
BACKGROUND: Successful homing of haemopoietic stem cells is the key step for the success of haploidentical bone marrow transplantation.
目的探讨HLA半相合外周血造血干细胞移植(PBSCT)急性白血病的疗效及安全性。
Objective To explore the efficiency and safety of HLA partially mismatched peripheral blood stem cell transplantation (PBSCT) for treatment of acute leukemia.
应用推荐